An Opioid Abuse-Deterrent Roadmap for the Pharmaceutical Industry

home.aspx

. https://pharmaceutical.report/Resources/Whitepapers/682e0c02-6264-4047-a7c7-174d1e848ed4_Executive Brief - An Opioid Abuse-Deterrent Roadmap for the Pharmaceutical Industry.pdf

An Opioid Abuse-Deterrent Roadmap for the Pharmaceutical Industry

whitepaper

Since 1999, the quantity of prescription opioids sold in the United States has nearly quadrupled, resulting in an average of 650,000 opioid prescriptions dispensed daily. Deaths from prescription opioids—drugs like oxycodone, hydrocodone, and methadone—have also quadrupled, causing more than 165,000 deaths in the U.S. within a 15-year time period (1999-2014). Additionally, an estimated 1.9 million people in the United States suffer from substance use disorders related to prescription opioid pain medicines.1 How much is the abuse epidemic costing the nation? It has been established that the health and social costs related to prescription opioid abuse total more than $55 billion each year, including $20 billion in emergency room and inpatient care for opioid poisonings. DOWNLOAD